Latest updates for Amgn
Fresh curated links around AMGN are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Amgen's Growth Engine Is Just Getting Started
- Argenx
- Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
cafepharma.com
/9 hours ago
Argenx
Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...
finance.yahoo.com
/1 month ago
Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy
finance.yahoo.com
/1 month ago
Zai Lab (ZLAB), Amgen (AMGN) Partner to Evaluate Combination Lung Cancer Therapy
seekingalpha.com
/1 month ago
Amneal: A Robust Drug Portfolio Worth Watching, Driving Further Upside Potential
cafepharma.com
/1 week ago
The fall of Amgen
The fall of Amgen Anonymous (not verified) Sun, 05/17/2026 - 08:33 field_thread_url https://cafepharma.com/boards/threads/the-fall-of-amgen.709419/...
pharmexec.com
/1 month ago
<![CDATA[Biogen Enters $5.6 Billion Agreement to Acquire Apellis Pharmaceuticals ]]>
fool.com
/3 weeks ago
Amylyx (AMLX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEThursday, May 7, 2026 at 8 a.m. ETCALL PARTICIPANTSCo-Chief Executive Officer — Justin KleeCo-Chief Executive Officer — Joshua CohenChief Commer...
seekingalpha.com
/1 week ago
argenx: The FcRn Franchise Is Becoming An Autoimmune Operating System
benzinga.com
/1 month ago
Apellis Stock Soars After Biogen Deal, Momentum Score Surges—Here's What Shareholders Get
Apellis jumps as Biogen agrees $5.6 Billion acquisition, offering $41/share plus milestones, boosting rare-disease portfolio. Importance Rank: ...
fool.com
/1 week ago
Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a Year
ADMA Biologics develops plasma-derived therapies for immune deficiencies and infectious diseases, leveraging a vertically integrated model.
seekingalpha.com
/2 weeks ago
AMN Healthcare Services, Inc. (AMN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
jdsupra.com
/1 month ago
Amgen and Shanghai Henlius/Organon Settle Denosumab BPCIA Litigation
On March 31, 2026, the District Court for the District of New Jersey entered a Consent Order and Judgment in the BPCIA litigation Amgen brought against Henlius and Organon concerni...
labiotech.eu
/1 month ago
Amgen pipeline’s next growth cycle: replacing its old blockbusters
Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines. The post Amgen pipeline’s next growth cycle: replacing its old block...
seekingalpha.com
/1 month ago
Assembly Biosciences, Inc. (ASMB) Presents at ESCMID Global 2026 - Slideshow
fool.com
/1 week ago
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
Alumis develops clinical-stage therapies targeting autoimmune and neuroinflammatory diseases through proprietary TYK2 inhibitors.
seekingalpha.com
/3 weeks ago
BioMarin outlines $3.825B-$3.925B 2026 revenue outlook driven by Amicus integration and 20% growth target
seekingalpha.com
/2 days ago
Ionis Pharmaceuticals: Bull Run Can Continue As Major Catalysts Approach
seekingalpha.com
/2 weeks ago
Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program
cafepharma.com
/1 month ago
Ambry Genetics
Ambry Genetics Anonymous (not verified) Mon, 04/27/2026 - 11:16 field_thread_url https://cafepharma.com/boards/threads/ambry-genetics.575501/...
seekingalpha.com
/1 month ago
Johnson & Johnson: Success In Multiple Myeloma Underpins $25B In Growth By 2030
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Amgn
feeds.benzinga.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source